Allianz Asset Management GmbH increased its position in shares of Ingredion Incorporated (NYSE:INGR – Free Report) by 11.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 842,763 shares of the company’s stock after acquiring an additional 89,335 shares during the quarter. Allianz Asset Management GmbH owned about 1.29% of Ingredion worth $115,930,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of INGR. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Ingredion in the 4th quarter valued at $27,000. Prospera Private Wealth LLC purchased a new stake in Ingredion during the 3rd quarter valued at about $41,000. Crews Bank & Trust purchased a new stake in Ingredion during the 4th quarter valued at about $48,000. Versant Capital Management Inc increased its holdings in shares of Ingredion by 431.0% in the fourth quarter. Versant Capital Management Inc now owns 446 shares of the company’s stock valued at $61,000 after purchasing an additional 362 shares during the period. Finally, Concord Wealth Partners raised its stake in shares of Ingredion by 82.6% in the third quarter. Concord Wealth Partners now owns 493 shares of the company’s stock worth $68,000 after purchasing an additional 223 shares during the last quarter. Hedge funds and other institutional investors own 85.27% of the company’s stock.
Insiders Place Their Bets
In other Ingredion news, CFO James D. Gray sold 54,869 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $146.76, for a total transaction of $8,052,574.44. Following the completion of the transaction, the chief financial officer now directly owns 12,795 shares in the company, valued at approximately $1,877,794.20. This represents a 81.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO James P. Zallie sold 10,815 shares of the stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $125.88, for a total transaction of $1,361,392.20. Following the transaction, the chief executive officer now directly owns 34,127 shares in the company, valued at approximately $4,295,906.76. The trade was a 24.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 65,685 shares of company stock worth $9,414,112. 1.80% of the stock is owned by corporate insiders.
Ingredion Price Performance
Ingredion (NYSE:INGR – Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The company reported $2.63 EPS for the quarter, beating the consensus estimate of $2.54 by $0.09. The company had revenue of $1.80 billion for the quarter, compared to analyst estimates of $1.82 billion. Ingredion had a net margin of 8.71% and a return on equity of 18.62%. The firm’s revenue was down 6.3% on a year-over-year basis. During the same quarter last year, the business earned $1.65 earnings per share. Equities research analysts forecast that Ingredion Incorporated will post 11.14 EPS for the current year.
Ingredion Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, January 21st. Investors of record on Thursday, January 2nd were issued a $0.80 dividend. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $3.20 dividend on an annualized basis and a yield of 2.50%. Ingredion’s payout ratio is 32.96%.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on INGR. StockNews.com lowered Ingredion from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Barclays upped their price objective on shares of Ingredion from $145.00 to $168.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. BMO Capital Markets reduced their target price on shares of Ingredion from $147.00 to $133.00 and set a “market perform” rating for the company in a report on Wednesday, February 5th. Oppenheimer lowered their price target on shares of Ingredion from $178.00 to $167.00 and set an “outperform” rating on the stock in a report on Wednesday, February 5th. Finally, Stephens cut their price target on Ingredion from $155.00 to $150.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 5th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $158.20.
Check Out Our Latest Stock Report on INGR
Ingredion Profile
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Further Reading
- Five stocks we like better than Ingredion
- How to Invest in Biotech Stocks
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- What Are Dividend Champions? How to Invest in the Champions
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Want to see what other hedge funds are holding INGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingredion Incorporated (NYSE:INGR – Free Report).
Receive News & Ratings for Ingredion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion and related companies with MarketBeat.com's FREE daily email newsletter.